Morepen Laboratories Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
Morepen Laboratories has been growing earnings at an average annual rate of 10.4%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 14.4% per year. Morepen Laboratories's return on equity is 13.9%, and it has net margins of 6.7%.
Anahtar bilgiler
10.4%
Kazanç büyüme oranı
7.4%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 17.5% |
Gelir büyüme oranı | 14.4% |
Özkaynak getirisi | 13.9% |
Net Marj | 6.7% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Morepen Laboratories nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 17,571 | 1,177 | 1,998 | 0 |
31 Mar 24 | 17,019 | 962 | 1,935 | 0 |
31 Dec 23 | 16,422 | 761 | 2,127 | 0 |
30 Sep 23 | 15,433 | 531 | 1,958 | 0 |
30 Jun 23 | 15,238 | 477 | 2,884 | 0 |
31 Mar 23 | 14,220 | 387 | 1,654 | 0 |
31 Dec 22 | 14,270 | 428 | 1,800 | 0 |
30 Sep 22 | 14,765 | 553 | 1,843 | 0 |
30 Jun 22 | 14,721 | 768 | 2,604 | 0 |
31 Mar 22 | 15,558 | 1,017 | 1,724 | 0 |
31 Dec 21 | 14,743 | 1,161 | 1,809 | 0 |
30 Sep 21 | 13,854 | 1,184 | 1,589 | 0 |
30 Jun 21 | 13,295 | 1,082 | 2,092 | 0 |
31 Mar 21 | 11,980 | 971 | 1,407 | 0 |
31 Dec 20 | 11,136 | 814 | 1,345 | 0 |
30 Sep 20 | 10,380 | 684 | 1,279 | 0 |
30 Jun 20 | 9,183 | 453 | 1,678 | 0 |
31 Mar 20 | 8,584 | 336 | 1,143 | 0 |
31 Dec 19 | 8,731 | 331 | 1,161 | 0 |
30 Sep 19 | 8,530 | 312 | 1,118 | 0 |
30 Jun 19 | 8,117 | 340 | 1,474 | 0 |
31 Mar 19 | 7,714 | 288 | 995 | 0 |
31 Dec 18 | 7,258 | 252 | 980 | 0 |
30 Sep 18 | 6,672 | 267 | 879 | 0 |
30 Jun 18 | 6,436 | 308 | 841 | 0 |
31 Mar 18 | 6,101 | 296 | 807 | 0 |
31 Mar 17 | 5,991 | 236 | 739 | 0 |
31 Mar 16 | 4,861 | 128 | 616 | 0 |
31 Mar 15 | 4,014 | 21 | 517 | 0 |
31 Mar 14 | 3,670 | -28 | 807 | 4 |
Kaliteli Kazançlar: 500288 has high quality earnings.
Büyüyen Kar Marjı: 500288's current net profit margins (6.7%) are higher than last year (3.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 500288's earnings have grown by 10.4% per year over the past 5 years.
Büyüme Hızlandırma: 500288's earnings growth over the past year (146.9%) exceeds its 5-year average (10.4% per year).
Kazançlar vs. Sektör: 500288 earnings growth over the past year (146.9%) exceeded the Pharmaceuticals industry 19.1%.
Özkaynak Getirisi
Yüksek ROE: 500288's Return on Equity (13.9%) is considered low.